Selective serotonin reuptake inhibitors associated with increased mortality risk in breast cancer patients in Northern Israel.

SSRI use prior to and after breast cancer diagnosis is associated with increased mortality in breast cancer patients. Additional research is needed to better understand mechanisms mediating this association.